Interview: Leonardo Vingiani – Director, ASSOBIOTEC, Italy
Leonardo Vingiani, Director of Assobiotec, discusses how the country’s biotech industry has evolved since 2009,…
Address: Via Giovanni da Procida 11, 20149 Milano,Italy
Tel: +39 02 34565306
Web: http://assobiotec.federchimica.it/
Set up in October 1986 within the Italian Federation of the Chemical Industry (Federchimica), Assobiotec is the Italian Association for the Development of Biotechnology, representing more than 120 companies and science & technology parks operating in Italy and involved in various biotech-related fields – pharmaceuticals, diagnostics, agro-food, fine chemicals, environment, processing industry and equipment. They include emerging biotech companies and small to medium enterprises, as well as the biotech divisions of large organisations.
Assobiotec is co-founder member of EuropaBio, the European Association for Bioindustries, created in 1996.
Assobiotec provides entrepreneurial support to Italian and EU biotech developments and is the landmark for Italian companies involved in production and marketing of products derived from biotech applications.
Assobiotec focuses its main attention on:
regulatory issues affecting production, marketing and use of biotechnology products and their standards harmonisation;
fiscal and financial policies aimed at motivating industrial innovation;
R&D, education and training projects and programmes.
Assobiotec’s policy is mainly dealing with:
monitoring legislation in the regulatory area;
representing Italian bioindustry at National and international level;
providing a regular forum for the exchange of information and initiatives of entrepreneurial relevance;
taking active part to the reviewing process concerning the rules on industrial property.
Assobiotec’s activities include:
close interaction with National and international trade organisations dealing with biotechnology;
regular contacts with Universities, fostering collaboration between academia and industry in research and education;
information services on commercial biotech applications, on patents and on R&D programmes implementation.
Leonardo Vingiani, Director of Assobiotec, discusses how the country’s biotech industry has evolved since 2009,…
Biotechnologies have a significant role to play bringing Italy towards a more knowledge-based economy. What is the…
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies…